Company
Trianabio
Unlocking the full potential of molecular glues to develop precision medicines and transform patient lives
Also known as TRIANA Biomedicines, Triana Biomedicines, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Triana Biomedicines, Inc.
- trianabio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel therapeutics to treat diseases.
Funding snapshot
- Total raised
- $230MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $120M2025-12-03
Funding rounds
- Round, 2025
- $120M2025-11-26, SEC form D sold, 20 investors
- Round, 2022
- $110M2022-04-06, Company stated
- Round, 2022
- $42.6M2022-01-28, SEC form D sold, 14 investors
- Round, 2021
- $10M2021-09-03, SEC form D sold, 1 investor
- Round, 2020
- $6M2020-05-22, SEC form D sold, 3 investors
Loading relationship preview